March 14, 2025 By Jim Hammerand Medtronic’s RDN GM shares reimbursement advice and his ‘airplane moment’
January 29, 2025 By Jim Hammerand Medtronic’s Project Gemini for next-gen renal denervation has a new target
January 16, 2025 By Jim Hammerand This Medtronic innovation ‘could be the biggest thing we ever do,’ CEO Geoff Martha says
January 10, 2024 By Jim Hammerand How alcohol could make renal denervation for hypertension faster and simpler
December 21, 2023 By Jim Hammerand Recor Medical CEO Lara Barghout on leadership lessons and what she looks for when hiring
December 8, 2023 By Jim Hammerand Medtronic execs: renal denervation for AFib could be on the horizon
October 24, 2023 By Sean Whooley Medtronic selects location for renal denervation tech manufacturing — if approved by FDA
August 25, 2023 By Jim Hammerand Engineers wanted: ReCor Medical’s hiring as its RDN system awaits FDA approval
August 24, 2023 By Jim Hammerand After Medtronic’s latest setback, what’s next for Symplicity Spyral RDN?
August 23, 2023 By Jim Hammerand Risks of Medtronic Symplicity Spyral renal denervation (RDN) outweigh benefits: FDA review panel
November 8, 2022 By Jim Hammerand What’s next for Medtronic RDN after Symplicity Spyral trial ‘surprise’?
